IL1 blockade in crystal-induced arthritis: Impact of disease duration and the inflammatory syndrome. Comments on the article by Couderc M. et al. " Efficacy of anakinra in articular chondrocalcinosis"

Joint Bone Spine

Volumn 80, Issue 1, 2013, Pages 115-116

  Verhoeven, Frank ^a   Prati, Clément ^a   Godfrin Valnet, Marie ^a   Guillot, Xavier ^a   Wendling, Daniel ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; INTERLEUKIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTHRITIS; CLINICAL ARTICLE; CRYSTAL INDUCED ARTHRITIS; DISEASE DURATION; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MALE; PSEUDOGOUT; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ANTIRHEUMATIC AGENTS; CHONDROCALCINOSIS; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE;

EID: 84872856107     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.09.002     Document Type: Letter

References (6)

1. Couderc M., Mathieu S., Glace B., et al. Efficacy of anakinra in articular chondrocalcinosis: report of three cases. Joint Bone Spine 2012, 79:330-331.
2. Molto A., Olivé A. Anti IL-1 molecules: new comers and new indications. Joint Bone Spine 2010, 77:102-107.
3. So A., De Smedt T., Revaz S., et al. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007, 9:R28.
4. Chen K., Fields T., Mancuso C.A., et al. Anakinra's efficacy is variable in refractory gout: report of ten cases. Semin Arthritis Rheum 2010, 40:210-214.
5. McGonagle D., Tan A.L., Madden J., et al. Successful treatment of resistant pseudogout with anakinra. Arthritis Rheum 2008, 58:631-633.
6. Announ N., Palmer G., Guerne P.A., et al. Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure. Joint Bone Spine 2009, 76:424-426.